Die Geschichte von Big Pharma- Bayer (IG Farben), FDA und dem AIDS Virus
Geschrieben von: Milos Pokimica
Medizinisch Begutachtet Von: Dr. Xiùying Wáng, M.D.
Aktualisiert am 4. August 2023Die Ernährungswissenschaft hat bereits vor Jahrzehnten alle Zusammenhänge zwischen Wohlstandskrankheiten und dem Verzehr tierischer Nahrungsmittel erklärt. Die meisten unserer Killer Nummer eins sind vermeidbar, aber es besteht kein Interesse daran, den aktuellen Geschäftszweig zu ändern. Die gesamte verfügbare Wissenschaft wird der Öffentlichkeit vorenthalten, und in Wirklichkeit spielt das keine Rolle.
Was den meisten Menschen bewusst ist, ist reine Propaganda. Ärzte sind gut, sie müssen einen hippokratischen Eid leisten, sie sind da, um einen zu heilen und zu helfen, und natürlich wird uns die Medizin eines Tages von allen Krankheiten befreien. Normalerweise, wenn Menschen mit der wahren Geschichte der großen Pharmakonzerne konfrontiert werden und die Wahrheit erkennen government itself has a network for suppressing the science and that individual men’s interest is not its primary goal, Normalerweise sagen sie, dass alles Vergangenheit ist. Heute haben wir mehr Demokratie und Freiheiten mit besserer staatlicher Kontrolle und so weiter.
Die Antwort ist nein. Wir haben noch weniger Freiheiten als nach dem Zweiten Weltkrieg. Wir wurden in Schulen einer Gehirnwäsche unterzogen und von den Medien mit psychologischer Forschung zur sozialen Kontrolle durchdrungen, aber sonst ist nichts anders. Die gleiche Struktur existiert und existiert nicht erst seit dem mittleren Alter, sondern sogar schon davor.
I will give one more recent example. You’d probably never know that Bayer (IG Farben) paid “tens of millions” of dollars to end a three-decade-long scandal in which the company sold HIV-contaminated blood products to hemophiliacs, thousands of whom later died of AIDS. Bayer is eventually forced into signing checks to individuals that acquired AIDS because, in the 1980s, the Cutter Biological section of Bayer neglected federal law and recruited gay men with high risk and intravenous drug users, and prisoners as donors of the blood that Cutter later used to produce Factor VIII and IX. It is a drug, the clotting product, that hemophiliacs need in order to not bleed to death. In 1997 Bayer was sentenced to pay 600 million into a compensation fund for hemophiliacs with HIV. About 20,000 individuals caught HIV from the blood.
Ironically, Bayer’s new hemophilia iPhone app got some coverage, as did Bayer’s hemophilia research grant to the University of Florida.
Am 16. Juli 1982 vermuteten die US-amerikanischen Zentren für die Kontrolle und Prävention von Krankheiten (CDC), dass drei Bluter an AIDS erkrankt seien. Epidemiologen begannen zu glauben, dass sich das Virus durch Blutermedikamente verbreitete, die sie einmal pro Woche injizierten. Die Medikamente wurden aus großen Pools gespendeten Plasmas verschiedener Personen hergestellt. Ein Großteil davon wurde vor der obligatorischen HIV-Testung gesammelt, oft von Homosexuellen und Drogenkonsumenten und in einigen Gefängnissen. Ohne einen Infektionstest konnten sie nicht feststellen, ob die Plasmaspender das Virus in sich trugen. Im Januar 1983 bestätigte der Leiter der Cutter Biological-Abteilung von Bayer in einem Brief, dass:
“There is strong evidence to suggest that AIDS is passed on to other people through … plasma products.”
These letters surfaced in trials and were found by some of the investigative journalists that later broke the story public. By May 1983, a Cutter competitor started producing a heat-treated concentrate that killed the virus, so France for example, and many other countries decided to halt all clotting concentrate imports. Cutter worried about losing consumers, so according to an enclosed memo: “want to give the impression that we continue improving our product without telling them that soon we were also going to have a heat-treated” concentrate. By June 1983, a Cutter letter to distributors to 20 countries said that:
“AIDS has become the center of irrational response in many countries” and that “This is of particular concern to us because of unsubstantiated speculations that certain blood products may transmit this syndrome.”
They lied, and many countries were still using an old concentrate. In February 1984, Cutter became the last of the four major blood product companies to get US approval to sell heated concentrate. They waited as long as possible. Still even after Cutter started to sell the new product, still for several more months, they continued making the old medicine. The reason was that the corporation had several fixed-price contracts and thought that the old product would be cheaper to produce. Bayer officials (responding on behalf of Cutter) responded with another lie: “because some customers doubted the new drug’s effectiveness,” some nations were slow to support registration of the new drug. Then they lied by telling that they had a shortage of plasma, which is used to make the medicine. For example, Taiwan was one country that still received the old HIV-infected drug. Hsu Chien-wen, an official at Taiwan’s health department, told in 2003 that Cutter had not appealed for approval to sell the heated medicine until July 1985. That was for an entire year and a half after doing so in the United States. In Hong Kong, for example, Cutter did not even need approval but only an import license in the 1980s to be able to import and sell the newer product in which normally takes one week. A company meeting notes that:
“There is excess inventory,”
Dies führte in Wirklichkeit dazu, dass das Unternehmen beschloss:
“Review international markets again to determine if more of this product can be sold.”
Because of the lack of control and corruption Cutter decided to dispose of stockpiles of older HIV-positive drugs to third world countries while selling the new, safer product in the West. If some of the people catch AIDS well, they can take Aspirin for pain. And of course, there are all third world countries, so it is going to go well with eugenic programs of depopulation of the planet. When hemophiliacs in Hong Kong all of the sudden start to test positive for HIV, local physicians raised the question of whether Cutter was dumping “AIDS tainted” medicine into less-developed countries. Cutter rejected the accusation, insisting that older drug had “no severe hazard risk” and was, in fact, the “same fine product we have supplied for years.” Hong Kong did not believe the lie, and when the local distributor asked for the newer product, Cutter responded that all of the new product was going to the US and Europe. For Hong Kong, and other third-world countries they could make an exception for a small amount for the “most vocal patients.” Meaning influential people that could potentially make a problem for them. So if you are a son of a politician, they will give you new safe stuff.
Die US-amerikanische Lebensmittel- und Arzneimittelbehörde hat dazu beigetragen, die Nachricht aus dem Blickfeld der Öffentlichkeit zu halten. Government is not there to protect you and never had been. In May 1985, the FDA’s regulator of blood products, Harry M. Meyer Jr., considering the companies had violated a voluntary arrangement to remove the old drug from the market, called directors of the corporations and directed them to comply. Cutter’s internal notes from their meeting show that Meyer required that the issue is:
“Quietly solved without alerting the Congress, the medical community and the public”
also noted that the FDA wanted the matter solved “quickly and quietly.” Also at that time, Cutter official wrote that:
“It appears there are no longer any markets in the Far East where we can expect to sell substantial quantities of nonheated-treated medicine.”
They sell AIDS-tainted medicine as long as possible with no empathy. The effects of all of this are impossible to calculate because there was no test for HIV, so we do not know how many people were infected with HIV before Cutter began selling its safer medicine or afterward. Cutter also sold the old medicine in Argentina, Indonesia, Japan, Malaysia, and Singapore after February 1984. Cutter shipped more than 100,000 vials of unheated concentrate, worth more than $4 million after it began selling the safer product. The sales continued partly because of Cutter’s desire to deplete stocks of the older medicine, and partly because of fixed-price contracts, for which the company believed the older product would be cheaper to make. U.S. Justice Department had never investigated any corporate executives. Bayer in the past even marketed heroin for children. That is the level of psychopathic nature of these people.
Verweise:
Ausgewählte Passagen aus einem Buch: Pokimica, Milos. Zum Veganer werden? Rückblick auf die Wissenschaft Teil 2. Kindle-Ausgabe., Amazon, 2018.
- McHenry L, Khoshnood M. Blood money: Bayer’s inventory of HIV-contaminated blood products and third world hemophiliacs. Account Res. 2014;21(6):389-400. doi: 10.1080/08989621.2014.882780. PMID: 24785997.
- Patienten mit Josefson-D.-Hämophilie erheben Klage gegen Bayer wegen kontaminierter Blutprodukte. BMJ. 14. Juni 2003;326(7402):1286. doi: 10.1136/bmj.326.7402.1286-g. PMID: 12805147; PMCID: PMC1151015.
Zusammenhängende Posts
Haben Sie Fragen zum Thema Ernährung und Gesundheit?
Ich würde gerne von Ihnen hören und sie in meinem nächsten Beitrag beantworten. Ich freue mich über Ihren Beitrag und Ihre Meinung und freue mich darauf, bald von Ihnen zu hören. Ich lade Sie auch dazu ein Folgen Sie uns auf Facebook, Instagram und Pinterest für weitere Inhalte zu Ernährung und Gesundheit. Sie können dort einen Kommentar hinterlassen und sich mit anderen Gesundheitsbegeisterten austauschen, Ihre Tipps und Erfahrungen teilen und Unterstützung und Ermutigung von unserem Team und unserer Community erhalten.
Ich hoffe, dass dieser Beitrag für Sie informativ und unterhaltsam war und dass Sie bereit sind, die gewonnenen Erkenntnisse anzuwenden. Wenn Sie diesen Beitrag hilfreich fanden, dann es teilen mit Ihren Freunden und Familienangehörigen, die ebenfalls davon profitieren könnten. Man weiß nie, wer auf seinem Weg zur Gesundheit vielleicht etwas Anleitung und Unterstützung braucht.
– Das könnte Ihnen auch gefallen –
Über Ernährung Lernen
Milos Pokimica ist Doktor der Naturheilkunde, klinischer Ernährungsberater, Autor für medizinische Gesundheit und Ernährung sowie Berater für Ernährungswissenschaften. Autor der Buchreihe Zum Veganer werden? Rückblick auf die Wissenschafter betreibt auch das Natürliche Gesundheit website GoVeganWay.com
Medizinischer Haftungsausschluss
GoVeganWay.com bietet Ihnen Rezensionen der neuesten Ernährungs- und Gesundheitsforschung. Die bereitgestellten Informationen stellen die persönliche Meinung des Autors dar und sind weder als Ersatz für professionelle medizinische Beratung, Diagnose oder Behandlung gedacht noch impliziert. Die bereitgestellten Informationen dienen ausschließlich Informationszwecken und sollen nicht als Ersatz für die Beratung, Diagnose und/oder medizinische Behandlung durch einen qualifizierten Arzt oder Gesundheitsdienstleister dienen.Ignorieren Sie niemals professionellen medizinischen Rat oder verzögern Sie die Suche nach medizinischer Behandlung, weil Sie etwas auf GoVeganWay.com gelesen oder über GoVeganWay.com darauf zugegriffen haben
Nehmen Sie NIEMALS Änderungen im Lebensstil oder irgendwelche Änderungen vor, die eine Folge von etwas sind, das Sie auf GoVeganWay.com gelesen haben, bevor Sie einen zugelassenen Arzt konsultieren.
Bei einem medizinischen Notfall rufen Sie sofort einen Arzt oder die Notrufnummer 911 an. GoVeganWay.com empfiehlt oder unterstützt keine bestimmten Gruppen, Organisationen, Tests, Ärzte, Produkte, Verfahren, Meinungen oder andere Informationen, die darin erwähnt werden könnten.
Herausgeber-Tipps –
Milos Pokimica ist Doktor der Naturheilkunde, klinischer Ernährungsberater, Autor für medizinische Gesundheit und Ernährung sowie Berater für Ernährungswissenschaften. Autor der Buchreihe Zum Veganer werden? Rückblick auf die Wissenschafter betreibt auch das Natürliche Gesundheit website GoVeganWay.com
Neueste Artikel –
Pflanzenbasierte Nachrichten
-
Black Mole With Oyster Mushrooms
on November 15, 2024
-
This Carrot Bacon BLT Is A Vegan Take On The Classic
on November 15, 2024
-
Meat And Dairy Products Mislabeled As Vegan And Vegetarian At COP29
on November 15, 2024
-
Jeremy Clarkson Says He ‘Doesn’t Particularly Like’ Sending Animals To Slaughter
on November 15, 2024
-
Creamy 10-Minute Vegan Chickpea Bowl
on November 15, 2024
-
Vegan ‘Snickers’ Protein Balls
on November 14, 2024
-
10 Recipes That Use In-Season Vegetables For Fall
on November 14, 2024
Top-Gesundheitsnachrichten – ScienceDaily
- New study shows how salmonella tricks gut defenses to cause infectionon November 15, 2024
A study uncovered how Salmonella, a major cause of food poisoning, can invade the gut despite the presence of protective bacteria.
- Scientists develop novel plug-and-play test to evaluate T cell immunotherapy effectivenesson November 15, 2024
A novel test enables real-time monitoring of T cells that have been engineered to fight cancer, after re-introduction into the body of a cancer patient. This simple and innovative test provides clinicians with the ability to track the function of these cancer-fighting cells over the course of the treatment.
- Meta-analysis links high-risk Epstein-Barr virus lineage to nasopharyngeal cancer in southern Chinaon November 15, 2024
Researchers have discovered a significant association between specific Epstein-Barr virus (EBV) variants and nasopharyngeal carcinoma (NPC). NPC is a cancer notably prevalent in southern China, where it is 20 times more common than in non-endemic regions of the world.
- Selenium carrier proteins: New starting point for cancer researchon November 15, 2024
A recent study unveiled a key enzyme involved in producing selenoproteins, opening new strategies for treating certain types of cancer in children.
- Scientists transform blood into regenerative materials, paving the way for personalized, blood-based, 3D-printed implantson November 15, 2024
Scientists have created a new ‘biocooperative’ material based on blood, which has shown to successfully repair bones, paving the way for personalised regenerative blood products that could be used as effective therapies to treat injury and disease.
- Zinc deficiency promotes Acinetobacter lung infection, study findson November 15, 2024
Researchers discovered an unexpected link between zinc deficiency, the pro-inflammatory cytokine interleukin-13 (IL-13), and Acinetobacter baumannii lung infection and demonstrated that blocking IL-13 prevented infection-associated death in an animal model. The findings suggest that anti-IL-13 antibodies, which are FDA-approved for use in humans, may protect against bacterial pneumonia in patients with zinc deficiency.
- Children exposed to antiseizure meds during pregnancy face neurodevelopmental risks, study findson November 15, 2024
Children born to mothers who take antiseizure medications to manage seizures and psychiatric conditions during pregnancy may face increased risks of neurodevelopmental conditions, according to new research.
PubMed, #Vegane Diät –
- Diabetes Remission After Radical Nephrectomy in a Geriatric Patient With Obesity and Type 2 Diabetes-34 Months’ Follow-Upon November 15, 2024
Diabetes mellitus significantly affects survival in patients with renal cell carcinoma undergoing nephrectomy, requiring personalized care. This case involved a 64-year-old man with type 2 diabetes (T2D) who underwent radical nephrectomy for renal cell carcinoma. He consented to a 1-year intensive lifestyle intervention (ILI), including a vegan diet (to lower calorie intake, reduce uric acid, support renal health, and promote weight loss), intermittent fasting, regular exercise, psychological…
- Use of Five Complementary Health Modalities Relevant to Lifestyle Medicine: A 2020 Survey of Northern California Adults Aged 35-79 yearson November 14, 2024
CONCLUSION: There is substantial opportunity to increase use of CH modalities within a LM approach to preventing and managing chronic health conditions.
- Obstetric healthcare experiences and information needs of Dutch women in relation to their vegan diet during pregnancyon November 13, 2024
CONCLUSIONS: Our data shows that only a minority of pregnant women following a vegan diet received information and recommendations about their diet from their healthcare providers. It is our recommendation that healthcare providers inquire about pregnant women’s diets, and refer those following a vegan diet to reliable sources of dietary information or to a specialized dietitian.
- Effects of a Vegetarian Diet on the Development of Thyroid Disorderson November 13, 2024
This study aims to explore the impact of different types of vegetarian diets on thyroid health, particularly focusing on the prevalence of thyroid disorders. Vegetarianism has had increasing popularity and has been particularly prominent in Asia, where a large proportion of the population has adopted a vegetarian diet, whereas in North America, the prevalence of vegetarianism remains very small. Vegetarian and vegan diets have been known to pose a risk of deficiencies in minerals and vitamins…
- Effects of vegetarian diets on blood lipids, blood glucose, and blood pressure: a systematic review and meta-analysison November 11, 2024
High blood lipids, blood glucose, or blood pressure (“3Bs”) are established risk factors for cardiovascular diseases. However, the effects of vegetarian diets on these parameters were inconsistent in previous meta-analyses. We conducted a systematic review and meta-analysis with comprehensive subgroup analyses, quality assessment, and sensitivity analyses to confirm the effects of vegetarian diets on 3Bs. The literature was searched from PubMed, Cochrane, and Web of Science databases from the…
Zufällige Beiträge –
Beliebte Beiträge -
Neuestes von PubMed, #pflanzliche Ernährung –
- Incipient resistance of the African maize stemborer, Busseola fusca (Lepidoptera: Noctuidae) to Cry2Ab2 maize in South Africaby Elrine Strydom on November 15, 2024
CONCLUSION: Therefore, MON 89034 is effectively a single-mode-of-action technology against B. fusca and carries an inherent high risk for the evolution of resistance. This study shows that the three B. fusca populations collected from locations with greater than expected damage to MON 89034 have resistance to the Cry2Ab2 protein and therefore to MON 89034 maize. This research emphasizes the importance of resistance monitoring and implementation of effective insect resistance management […]
- Exploratory dietary patterns, the global diet quality score, and their associated socio-demographic factors among young adults in Rwanda: a cross-sectional study using a food list-validated,…by Phenias Nsabimana on November 15, 2024
CONCLUSION: This study identified distinct dietary patterns among adult population of Rwanda, suggesting a nutritional transition associated with urbanization. The findings highlight the need for further research into the relationships between diet, obesity, and metabolic syndrome in Rwandan population.
- Modulating the gut microbiota in Crohn’s disease: a pilot study on the impact of a plant-based diet with DNA-based monitoringby Stine Karstenskov Østergaard on November 15, 2024
INTRODUCTION: Crohn’s Disease (CD) is characterized by chronic intestinal inflammation and dysbiosis. This study aimed to investigate the effects of a plant-based diet (PBD) on gut microbiota composition and inflammation in CD patients and assess the utility of trnL gene sequencing for monitoring dietary adherence.
- Isolated Mediterranean foraging: wild greens in the matrifocal community of Olympos, Karpathos Island, Greeceby Andrea Pieroni on November 14, 2024
CONCLUSION: Cross-cultural foraging comparison is crucial for better understanding the circulation, exchange, and evolution of local plant knowledge under the MD umbrella. Our study assesses, in particular, how noteworthy phytolinguistic differences indicating different ancient trajectories of cultural encounters/exchanges may not necessarily be reflected in differences in terms of plant reports. As often postulated in linguistic ethnobiology, ancient linguistic labels sometimes remain as […]
- One Month Whole Food Plant-Based Nutrition Educational Program Lowers LDL, A1C, and Decreases Inflammatory Markersby Sandra Musial on November 14, 2024
Lifestyle-related chronic disease increases in the United States have led to the need for innovative programs targeting dietary choices. Based on growing evidence supporting whole food plant-based (WFPB) nutrition to improve overall health, we devised a one-month WFPB intervention program, Jumpstart Your Health! (JYH), to introduce and encourage adoption of the WFPB dietary lifestyle. This paper investigates its effects on various health indicators associated with cardiovascular and metabolic…
- Dementia and Cognitive Decline: A HEALM Approachby Ecler E Jaqua on November 14, 2024
Dementia and cognitive decline pose significant global public health challenges, with prevalence expected to rise in the coming decades. Lifestyle medicine offers a promising approach to mitigating cognitive issues through six key interventions: diet, physical activity, restorative sleep, social connections, stress management, and avoiding risky substances. Traditional methods like randomized controlled trials (RCTs) have limitations in capturing the long-term impacts of these interventions. […]